Sam-Ace participates in Pharmaceutical Society of Nigeria (PSN) Ijele’2026 Conference in Anambra State

The pharmaceutical industry came alive with conversations, new perspectives and meaningful connections as Sam-Ace participated in the Pharmaceutical Society of Nigeria (PSN) 99th Annual National Conference, held at the International Conference Centre, Awka, Anambra State from 2nd to 7th November 2026. The conference opened on 2nd November, bringing together professionals and stakeholders from across the pharmaceutical and healthcare sectors for an exciting week of learning, engagement and industry collaboration.

Representing the company was its Managing Director, Dr. Sam Olawoye, accompanied by members of the management team and other representatives from different departments. Their participation reflected their commitment to staying connected to developments within the pharmaceutical sector, building valuable professional relationships and contributing to conversations shaping the future of healthcare and pharmaceutical practice in Nigeria.

The conference was particularly enriching, with insightful speeches and contributions from the President of the Pharmaceutical Society of Nigeria, Pharm. Ayuba Tanko Ibrahim, FPSN, and the Registrar of the Pharmacy Council of Nigeria, Pharm. Ibrahim Babashehu Ahmed, FPSN, FPCPharm, FCAI. Their addresses offered valuable perspectives on the evolving pharmaceutical landscape, professional responsibilities, regulatory expectations, industry development and the importance of maintaining high standards in pharmaceutical practice.

Their messages also provided an opportunity for participants to reflect on the changing role of pharmacists and pharmaceutical organisations in strengthening healthcare delivery, improving access to quality medicines and advancing the profession in Nigeria. These sessions were among the highlights of the conference for the Sam-Ace delegation, reinforcing the importance of continuous learning, professional engagement and collaboration.

Held under the theme, "One Health, One Pharmacy: Bridging Knowledge, Practice and Policy for National Impact," the conference brought together pharmacists, pharmaceutical manufacturers, industry executives, regulators, academics and other healthcare stakeholders. It provided a platform for discussing important issues affecting the profession, including pharmaceutical manufacturing, medicines security, regulatory excellence, innovation and the future of healthcare.

The experience was both exciting and insightful and the programme offered opportunities to interact with colleagues and industry stakeholders, exchange professional experiences and gain fresh perspectives on the evolving demands of the pharmaceutical landscape. Beyond the formal sessions, the conference created an atmosphere for networking and relationship-building. Members of the team engaged with fellow participants, reconnected with familiar faces and established new professional contacts, reinforcing the value of collaboration within the industry.

The company's participation also provided an opportunity to showcase its identity and strengthen awareness of its pharmaceutical manufacturing operations. With a portfolio focused on Beta-Lactam Antibiotics and Oral Rehydration Salts (ORS), Sam-Ace continues to engage with the wider pharmaceutical community while strengthening its commitment to quality manufacturing and better healthcare solutions.

The conference was not just an opportunity to attend professional sessions; it was also an occasion to celebrate the pharmaceutical community, exchange ideas and appreciate the collective efforts of those working to move the industry forward.

As IJELE 2026 comes to a close on 7th November, the Sam-Ace team returned with valuable insights, renewed professional connections and a stronger appreciation of the opportunities and responsibilities within the pharmaceutical sector.